Axena Health Joins AARP Accelerator’s AgeTech Collaborative™ to Advance Women’s Pelvic Health Innovations
Axena Health, Inc. (Axena Health), a leading medical device company dedicated to redefining the standard of care for women’s pelvic health, has announced its selection to participate in the AgeTech Collaborative™ from AARP Accelerator. This prestigious program is an intensive eight-week initiative designed to accelerate growth-stage companies with innovative AgeTech solutions aimed at improving quality of life for aging populations.
The announcement marks a significant milestone for Axena Health as it continues to expand access to clinically validated, non-invasive treatments for women experiencing urinary incontinence, a condition that affects millions globally and becomes increasingly prevalent with age. The company’s participation in the AgeTech Collaborative™ aligns seamlessly with its mission to deliver effective, first-line care options that address the challenges of bladder leakage while empowering women to take control of their pelvic health.
Axena Health’s Mission: Transforming Pelvic Health Care
Axena Health has rapidly emerged as a pioneer in the field of women’s pelvic health by offering solutions that go beyond traditional treatment approaches. With a focus on non-invasive, clinically validated interventions, the company aims to modernize the standard of care and address the unmet needs of women who experience bladder leakage, medically known as urinary incontinence.
Randy Pritchard, CEO of Axena Health, expressed enthusiasm about joining the program, stating: “We’re thrilled to join the AgeTech Collaborative™ from AARP Accelerator program as we continue to improve the standard of care for women’s pelvic health. The mission aligns with our commitment to support all women experiencing bladder leakage, particularly as urinary incontinence becomes more common as women navigate the challenges of aging, especially after 50. Participation in the accelerator program will be invaluable as we work to expand access to our clinically proven Leva Pelvic Health System and ensure more women receive the effective, first-line pelvic healthcare treatment they deserve.”
Through its innovative solutions, Axena Health addresses a critical healthcare gap. Urinary incontinence is often underdiagnosed and undertreated, despite its significant impact on physical, emotional, and social well-being. Women over the age of 50 are particularly susceptible due to hormonal changes, pelvic floor muscle weakening, and other age-related factors. By providing evidence-based interventions, Axena Health empowers women to regain confidence and improve their quality of life without resorting to invasive procedures or long-term reliance on medications.
The Leva® Pelvic Health System: A Clinically Proven Solution
At the heart of Axena Health’s offering is the Leva® Pelvic Health System, a cutting-edge medical device designed to guide women through structured pelvic floor muscle training (PFMT). PFMT is recognized by leading medical authorities as the recommended first-line treatment for urinary incontinence. Leva transforms this approach into a modern, accessible, and patient-friendly experience, leveraging technology to monitor and optimize pelvic muscle exercises.
Leva’s program is designed as a 12-week comprehensive treatment protocol, backed by 11 peer-reviewed clinical studies demonstrating its efficacy. Data shows that women using the system can reduce bladder leakage by up to 80 percent, with treatment benefits lasting at least two years. The system’s clinical credibility and robust research foundation set it apart from other interventions, offering women a reliable and non-invasive alternative to surgery or long-term pharmacologic therapy.
The Leva system integrates real-time feedback and personalized training regimens, enabling women to track their progress and receive guidance on exercise technique. This technological approach ensures adherence, maximizes treatment outcomes, and fosters a sense of empowerment by giving women direct control over their pelvic health journey.
AgeTech Collaborative™ from AARP Accelerator: Empowering Innovation for Aging Populations
The AgeTech Collaborative™ from AARP Accelerator is a highly selective program that identifies and supports innovative companies developing technologies that make aging easier and more fulfilling. Participants in the program gain access to a wealth of resources, including AARP research, consumer insights, subject matter expertise, growth marketing strategies, and UI/UX design consultation.
Companies are sourced through nationwide pitch events, and participation is by invitation only, highlighting the program’s rigorous selection criteria. The initiative focuses on supporting meaningful technological advancements that enhance independence, improve health outcomes, and empower individuals to choose how they live as they age.
Axena Health’s inclusion in this program reflects the company’s commitment to delivering clinically validated, technology-driven solutions that address real-world challenges faced by aging women. By collaborating with AARP Accelerator, Axena Health will gain critical insights into consumer needs, refine its growth strategy, and explore new avenues for reaching a broader population of women who can benefit from its treatments.
Strategic Alignment and Future Goals
The partnership between Axena Health and the AgeTech Collaborative™ underscores the strategic alignment between the company’s mission and the program’s focus on improving the lives of older adults. By participating in this initiative, Axena Health aims to accelerate the adoption of the Leva Pelvic Health System, expand educational outreach, and enhance access to non-invasive, clinically proven treatments.
The company is committed to addressing the unique needs of women over 50, who often face compounded challenges related to pelvic health, mobility, and overall wellness. Through participation in the accelerator, Axena Health plans to leverage AARP’s extensive network and research capabilities to better understand the barriers women face in seeking care and to optimize the delivery of its solutions to meet these needs effectively.
Moreover, Axena Health anticipates that the program will facilitate strategic partnerships, provide insights into consumer behavior, and enhance product development efforts. These benefits will support the company’s broader vision of redefining the standard of care in pelvic health and ensuring that all women have access to treatments that are safe, effective, and supported by clinical evidence.
A Broader Impact on Women’s Health
Urinary incontinence is a widespread and often stigmatized condition, with an estimated 25 to 45 percent of women experiencing some degree of bladder leakage during their lifetime. The prevalence increases significantly with age, impacting daily activities, mental health, and social participation. Despite its frequency, many women delay seeking care due to embarrassment, lack of awareness, or limited access to effective treatments.
By offering the Leva Pelvic Health System, Axena Health addresses these barriers, providing a discreet, home-based solution that empowers women to take control of their pelvic health without invasive interventions. The system’s clinical validation ensures that women receive a scientifically supported treatment that can deliver meaningful improvements in their quality of life.
Participation in the AgeTech Collaborative™ further enhances Axena Health’s ability to reach older populations, align its offerings with consumer expectations, and deliver education on the importance of early intervention for pelvic floor dysfunction. This combination of technology, clinical evidence, and patient-centric design represents a holistic approach to transforming women’s health care and promoting positive aging experiences.
